Resources

One of the keys to Avid's mammalian bioprocessing success is maintaining a a culture of communication and collaboration where our employees are equipped with the best technologies and are empowered to create innovative solutions at every stage of production. Hear from Avid’s thought leaders on topics ranging from high-throughput process...

Building a viral vector manufacturing facility from the ground up. Members of Avid Bio's leadership team discuss the key considerations that went into designing their viral vector manufacturing facility and how it will deliver quality viral vector process development and CGMP manufacturing.

Charlotte Barker (Editor, BioInsights) speaks to Elie Hanania, PhD (Vice President of Process Development Viral Vector Technologies, Avid Bioservices) about the current status and future manufacturing of AAV-based gene therapies, including how to streamline large-scale manufacturing.

Learn more about how to optimize viral vector processes in manufacturing with a holistic approach by identifying the key steps and components that have the highest impact on process outcome and quality..

Adapting an existing facility for viral vector manufacturing purposes presents challenges that have the potential to impact safety and integrity. A dedicated facility, built from the ground up, enables CDMOs to address areas of concern specific to viral vectors. Learn more about how Avid’s purpose-built approach is answering the industry...